| Sherer Family Medicine, Pc | |
|
7240 S Us Highway 231 Huntingburg IN 47542-9450 | |
| (812) 683-9020 | |
| (812) 683-9024 |
| Full Name | Sherer Family Medicine, Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 7240 S Us Highway 231, Huntingburg, Indiana |
| Authorized Official Name and Position | Ryan J. Sherer (VP) |
| Authorized Official Contact | 8126839020 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sherer Family Medicine, Pc 7240 S Us Highway 231 Huntingburg IN 47542-9450 Ph: (812) 683-9020 | Sherer Family Medicine, Pc 7240 S Us Highway 231 Huntingburg IN 47542-9450 Ph: (812) 683-9020 |
| NPI Number | 1609903269 |
|---|---|
| Provider Enumeration Date | 02/28/2007 |
| Last Update Date | 06/16/2018 |
| Medicare PECOS PAC ID | 9032179114 |
|---|---|
| Medicare Enrollment ID | O20041013000632 |
News Archive
There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at
Despite some successes, predicting cancer outcomes based on the molecular signatures in cancer cells remains a major challenge. A new effort, funded by the National Cancer Institute and led by researchers at the University of California, Santa Cruz, aims to clear several key roadblocks that have stymied progress in this field.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
In today's fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609903269 | NPI | - | NPPES |
| 219390 | Other | MEDICARE GROUP | |
| 200373300 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 50004627A (Indiana) | Primary |
| Provider Name | Ryan J Sherer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1417955998 PECOS PAC ID: 7012977192 Enrollment ID: I20041016000150 |
News Archive
There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at
Despite some successes, predicting cancer outcomes based on the molecular signatures in cancer cells remains a major challenge. A new effort, funded by the National Cancer Institute and led by researchers at the University of California, Santa Cruz, aims to clear several key roadblocks that have stymied progress in this field.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
In today's fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.
› Verified 2 days ago
| Provider Name | Rachelle E Sherer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1508863788 PECOS PAC ID: 9830159912 Enrollment ID: I20041016000163 |
News Archive
There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at
Despite some successes, predicting cancer outcomes based on the molecular signatures in cancer cells remains a major challenge. A new effort, funded by the National Cancer Institute and led by researchers at the University of California, Santa Cruz, aims to clear several key roadblocks that have stymied progress in this field.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
In today's fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.
› Verified 2 days ago
News Archive
There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at
Despite some successes, predicting cancer outcomes based on the molecular signatures in cancer cells remains a major challenge. A new effort, funded by the National Cancer Institute and led by researchers at the University of California, Santa Cruz, aims to clear several key roadblocks that have stymied progress in this field.
BioMimetic Therapeutics, Inc. today announced that it has received orphan drug designation from the Food and Drug Administration for its protein therapeutic, recombinant human platelet derived growth factor, to be used in conjunction with autograft and/or commercially available osteochondral allograft for the treatment of osteochondritis dissecans of the knee, elbow or ankle.
In today's fast-paced health care environment, it is critical that hospitals keep their staff updated on using the latest imaging technology available. Currently, most facilities receive the majority of their diagnostic imaging equipment training when a new system is delivered. Toshiba America Medical Systems, Inc. recognizes the importance of maintaining that training edge and now is providing customers with an option – Performance Plus.
› Verified 2 days ago
Memorial Hospital And Health Care Center Huntingburg Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 E 22nd St, Huntingburg, IN 47542 Phone: 812-683-3612 | |
Crossroads Behavioral Health Providers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1900 Medical Arts Dr, Huntingburg, IN 47542 Phone: 270-900-1461 | |
The Huntingburg Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 E 17th St, Huntingburg, IN 47542 Phone: 812-683-3612 Fax: 812-683-2819 | |
Huntingburg Medical Center, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1706 Medical Arts Dr, Suite 3, Huntingburg, IN 47542 Phone: 812-683-4900 Fax: 812-683-3206 |